Adipocyte fatty acid-binding protein and metabolic syndrome
Qiu-gui Li
Abstract
Qiu-gui Li
Abstract
Adipocyte fatty acid-binding protein(A-FABP) is a new-found adipocytokine which secreted from adipocyte. Animal experiment indicated that A-FABP can promote the development of insulin resistance, dyslipidemia, type 2 diabetes mellitns and artheroaclerosis in metabolic syndrome. Population studies found that serum A-FABP level might be an independent biomarker of metabolic syndrome. The effect of A-FABP in treating metabolic syndrome is concerned by people gradually. This article introduces the distribution, structure, property of A-FABP, and the relationship between A-FABP and the components of metabolic syndrome. Key words: Adipecyte fatty acid binding protein; Metabolic syndreme; Adipocyte
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Adipocyte fatty acid-binding protein(A-FABP) is a new-found adipocytokine which secreted from adipocyte. Animal experiment indicated that A-FABP can promote the development of insulin resistance, dyslipidemia, type 2 diabetes mellitns and artheroaclerosis in metabolic syndrome. Population studies found that serum A-FABP level might be an independent biomarker of metabolic syndrome. The effect of A-FABP in treating metabolic syndrome is concerned by people gradually. This article introduces the distribution, structure, property of A-FABP, and the relationship between A-FABP and the components of metabolic syndrome. Key words: Adipecyte fatty acid binding protein; Metabolic syndreme; Adipocyte
Key concepts: Metabolic syndrome, Insulin resistance, Dyslipidemia, adipocyte protein 2, Fatty acid-binding protein, Adipocyte, Internal medicine, Endocrinology